The global health burden of noncommunicable diseases (NCDs) is large and growing, as this group of diseases already accounts for 70% of total deaths (1). Global evidence indicates that the high health burden of NCDs translates into significant economic and social costs that threaten to diminish the quality of life of millions of individuals, impoverish families, jeopardize universal health coverage, and increase health disparities within and between countries (2). On the other hand, less than 2% of global donor health funding is directed towards preventing these diseases (3). Recognizing the trends in NCDs and the global evidence on their multidimensional costs and their potential to hamper development, Goal 3 of the Sustainable Development Goals includes a specific target (Target 3.4) of reducing mortality from NCDs by one-third by 2030 (4).
United Nations Inter-Agency Task Force on NCDs (UNIATF), the Organization for Economic Co-operation and Development (OECD), the Economic Commission for Latin America and the Caribbean (ECLAC), the United States Centers for Disease Control and Prevention (CDC), and the Public Health Agency of Canada (PHAC), to support regional efforts to implement PAHO/WHO Action Plans for the Prevention and Control of Noncommunicable Diseases through policy-focused evidence on the economics of NCDs. This thematic issue of the Pan American Journal of Public Health is part of a continued collaboration between PHAC and PAHO/WHO to facilitate intragovernmental dialogue for a better understanding of NCD issues by making economic evidence available in the Americas, and to assist PAHO/WHO Member States in integrating economic approaches into their NCD prevention and control policies. It is our hope that national health authorities will use the evidence presented in this issue to more vigorously advocate for the comprehensive development, financing, and implementation of evidence-based multisectoral policies on NCDs and their related risk factors.
